Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults by Hoan Jong Lee, Moon-Hyun Chung, Woo Joo Kim, Young Jin Hong, Kyong Min Choi, Jina Lee, Chi Eun Oh, Jo Anne Welsch, Kyung-Hyo Kim, Ki Bae Hong, Alemnew F. Dagnew, Hans Bock, Peter M. Dull, Tatjana Odrljin

Subjects: Get full text

Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents by Beatriz P. Quiambao, Ashish Bavdekar, Anand Prakash Dubey, Hemant Jain, Devayani Kolhe, Véronique Bianco, Jacqueline M. Miller, Marie Van der Wielen

Subjects: Get full text

An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine by Pavitra Keshavan, Michele Pellegrini, Kumaran Vadivelu-Pechai, Michael Nissen

Subjects: Get full text

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age by Timo Vesikari, Paula Peyrani, Chris Webber, Marie Van Der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Emmanuel Aris, Mark Cutler, Ping Li, John L. Perez

Subjects: Get full text

Impact of Meningococcal ACWY Vaccination Program during 2017–18 Epidemic, Western Australia, Australia by Krist Ewe, Parveen Fathima, Paul Effler, Carolien Giele, Peter Richmond

Subjects: Get full text

Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis by Andrea Conti, Gaia Broglia, Chiara Sacchi, Fabrizia Risi, Francesco Barone-Adesi, Massimiliano Panella

Subjects: Get full text

Different Long-Term Duration of Seroprotection against <i>Neisseria meningitidis</i> in Adolescents and Middle-Aged Adults after a Single Meningococcal ACWY Conjugate Vaccination i... by Milou Ohm, Debbie M. van Rooijen, Axel A. Bonačić Marinović, Mariëtte B. van Ravenhorst, Marieke van der Heiden, Anne-Marie Buisman, Elisabeth A.M. Sanders, Guy A.M. Berbers

Subjects: Get full text